Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

Desonide - Generic Drug Details

« Back to Dashboard

What are the generic sources for desonide and what is the scope of desonide patent protection?

Desonide
is the generic ingredient in four branded drugs marketed by Perrigo New York, Galderma Labs Lp, G And W Labs Inc, Hi-tech Pharmacal, Bayer Hlthcare, Taro, Fougera Pharms, Taro Pharm, and Aqua Pharms, and is included in fourteen NDAs. There are seven patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Desonide has seventy-four patent family members in twenty-five countries.

There are twenty-nine drug master file entries for desonide. Fourteen suppliers are listed for this compound.

Summary for Generic Name: desonide

Tradenames:4
Patents:7
Applicants:9
NDAs:14
Drug Master File Entries: see list29
Suppliers / Packagers: see list14
Bulk Api Vendors: see list26
Clinical Trials: see list2
Patent Applications: see list5,695
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:desonide at DailyMed

Pharmacology for Ingredient: desonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms
VERDESO
desonide
AEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes9,492,384► SubscribeY ► Subscribe
Perrigo New York
DESONIDE
desonide
OINTMENT;TOPICAL017426-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Fougera Pharms
DESONIDE
desonide
OINTMENT;TOPICAL075751-001Mar 12, 2001ABRXNoNo► Subscribe► Subscribe
Taro
DESONIDE
desonide
CREAM;TOPICAL073548-001Jun 30, 1992ABRXNoNo► Subscribe► Subscribe
Fougera Pharms
DESONIDE
desonide
LOTION;TOPICAL075860-001Mar 19, 2002ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot